News Release

Mallinckrodt to Present at Goldman Sachs 2014 Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--Jun. 4, 2014-- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, will present at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA on Wednesday, June 11. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 10:00AM PDT.

A live audio webcast of the presentation can be accessed at Mallinckrodt’s Investor Relations website: and a replay will be available for 14 days following the presentation.


Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company’s Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in approximately 65 countries. The company’s fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit

Source: Mallinckrodt

John Moten, 314-654-6650
Vice President, Investor Relations
Lynn Phillips, 314-654-3263
Manager, Communications